Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public?
12 ArticlesLife Sciences ×
Paradigm Changing Technologies in Oncology
Microbiome: Hope or Hype?
How to Apply the Golden Rule of Research to your Trial Master File
This webinar evaluated the regulations that support GDP, best practices on how document contributors can apply the golden rule of research to their TMF, how to avoid writing too many and unnecessary Note-to-Files (NTFs), and tips on becoming inspection ready and staying that way.
Biotech and Pharma Licensing Negotiations
The Nuts & Bolts of Selecting a Contract Research Organization
This webinar evaluated how to determine internal champions/selection committees, strategic sourcing/procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value.
Getting Ready for a Biopharma Partnering Deal
Patient Engagement Best Practices
What's Hot and What's Not in Oncology Licensing in 2020?
M&A and Capital Raising for Medical Groups, Life Sciences and Healthcare Companies
This webinar gives medical groups, life sciences, and healthcare companies in the lower middle market an understanding of financing and M&A alternatives available, the role of financial buyers, key issues around selling equity in your business, and the typical financing and M&A process.
Adoptive Cell Therapy in Solid Tumors
Predictable Failure (And How to Avoid It) for Early-Stage Life Science Companies
In this webinar, Dr. Lucia Mokres breaks down the six major stakeholder categories relevant to most life science companies, and shares key strategies for closing the knowledge gap between founders and their market success.